Search Result "RHEC"
Asymmetric 1,3-Dipolar Cycloaddition of Chiral α, β-Unsaturated-γ-Sultams with Nitrile Oxides and Nitrones
Journal: Letters in Organic Chemistry
Volume: 1 Issue: 1 Year: 2004 Page: 63-66
Author(s): H. Zhang, W. H. Chan, Albert W.M. Lee, P.- F. Xia, W. Y. Wong
Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 55-78
Author(s): Y. A. Ivanenkov, K. V. Balakin, Y. Lavrovsky
Immune Restoration Disease: A Consequence of Dysregulated Immune Responses After HAART
Journal: Current HIV Research
Volume: 2 Issue: 3 Year: 2004 Page: 235-242
Author(s): Shelley F. Stone, Patricia Price, Martyn A. French
New Vessel Formation in the Central Nervous System During Tumor Growth, Vascular Malformations, and Moyamoya
Journal: Current Neurovascular Research
Volume: 3 Issue: 3 Year: 2006 Page: 237-245
Author(s): Michael Lim, Samuel Cheshier, Gary K. Steinberg
Pharmacology of Adenosine A2A Receptors and Therapeutic Applications
Journal: Current Topics in Medicinal Chemistry
Volume: 3 Issue: 4 Year: 2003 Page: 413-426
Author(s): Bertil B. Fredholm, Rodrigo A. Cunha, Per Svenningsson
Anticancer Active Illudins: Recent Developments of a Potent Alkylating Compound Class
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2011 Page: 790-807
Author(s): R. Schobert, S. Knauer, S. Seibt, B. Biersack
Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 6 Year: 2006 Page: 491-517
Author(s): Torsten Becker, Sebastian Dziadek, Sven Wittrock, Horst Kunz
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 6 Year: 2005 Page: 393-419
Author(s): Christian Hafner, Albrecht Reichle, Thomas Vogt